1-5 of 5
Julien Adam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Plasma CD27, a Surrogate of the Intratumoral CD27–CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma

Nadine Benhamouda, Ikuan Sam, Nicolas Epaillard, Alain Gey, Letuan Phan, Hang Phuong Pham, Nadège Gruel, Antonin Saldmann, Joséphine Pineau, Milena Hasan, Valentin Quiniou, Camille Nevoret, Virginie Verkarre, Valentina Libri, Sebastien Mella, Clémence Granier, Chloe Broudin, Patrice Ravel, Eléonore De Guillebon, Laetitia Mauge, Dominique Helley, Bernd Jabla, Nathalie Chaput, Laurence Albiges, Sandrine Katsahian, Julien Adam, Arnaud Mejean, Olivier Adotevi, Yann A. Vano, Stéphane Oudard, Eric Tartour
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (22): 4983–4994.
https://doi.org/10.1158/1078-0432.CCR-22-0905
Published: 14 November 2022
View article titled, Plasma CD27, a Surrogate of the Intratumoral CD27–CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma
Open the PDF for Plasma CD27, a Surrogate of the Intratumoral CD27–CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic Melanoma

Isabelle Girault, Julien Adam, Shensi Shen, Séverine Roy, Caroline Brard, Sara Faouzi, Emilie Routier, Jéremy Lupu, Sarah Warren, Kristina Sorg, SuFey Ong, Pascale Morel, Jean-Yves Scoazec, Stéphan Vagner, Caroline Robert
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (3): 518–525.
https://doi.org/10.1158/1078-0432.CCR-21-1229
Published: 01 February 2022
View article titled, A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic Melanoma
Open the PDF for A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade

Stéphane Terry, Cécile Dalban, Nathalie Rioux-Leclercq, Julien Adam, Maxime Meylan, Stéphanie Buart, Antoine Bougoüin, Alexandra Lespagnol, Frédéric Dugay, Irelka Colina Moreno, Guillaume Lacroix, James B. Lorens, Gro Gausdal, Wolf H. Fridman, Fathia Mami-Chouaib, Nathalie Chaput, Benoit Beuselinck, Sylvie Chabaud, Janice Barros-Monteiro, Yann Vano, Bernard Escudier, Catherine Sautès-Fridman, Laurence Albiges, Salem Chouaib
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (24): 6749–6760.
https://doi.org/10.1158/1078-0432.CCR-21-0972
Published: 15 December 2021
View article titled, Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade
Open the PDF for Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade in another window
Includes: Supplementary data
Journal Articles

Long-term Outcomes of Oral Vinorelbine in Advanced, Progressive Desmoid Fibromatosis and Influence of CTNNB1 Mutational Status

Olivier Mir, Charles Honoré, Ali N. Chamseddine, Julien Dômont, Sarah N. Dumont, Andrea Cavalcanti, Matthieu Faron, Françoise Rimareix, Leila Haddag-Miliani, Cécile Le Péchoux, Antonin Levy, Charles Court, Sylvain Briand, Elie Fadel, Olaf Mercier, Arnaud Bayle, Anaïs Brunet, Carine Ngo, Etienne Rouleau, Julien Adam, Axel Le Cesne
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (23): 6277–6283.
https://doi.org/10.1158/1078-0432.CCR-20-1847
Published: 01 December 2020
View article titled, Long-term Outcomes of Oral Vinorelbine in Advanced, Progressive Desmoid Fibromatosis and Influence of <em>CTNNB1</em> Mutational Status
Open the PDF for Long-term Outcomes of Oral Vinorelbine in Advanced, Progressive Desmoid Fibromatosis and Influence of <em>CTNNB1</em> Mutational Status in another window
Includes: Supplementary data
Journal Articles

Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC

Luc Friboulet, Daniel Barrios-Gonzales, Frédéric Commo, Ken André Olaussen, Stephan Vagner, Julien Adam, Aïcha Goubar, Nicolas Dorvault, Vladimir Lazar, Bastien Job, Benjamin Besse, Pierre Validire, Philippe Girard, Ludovic Lacroix, Johanna Hasmats, Fabienne Dufour, Fabrice André, Jean-Charles Soria
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (17): 5562–5572.
https://doi.org/10.1158/1078-0432.CCR-11-0790
Published: 01 September 2011
View article titled, Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC
Open the PDF for Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC in another window
Includes: Supplementary data